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Objective: Popliteal artery aneurysm (PAA) is uncommon. The clinical presentation of PAA includes rupture, embolism,
and thrombosis. In this article, we evaluate the results of our 20-year experience with surgical management of PAAs,
analyzing the role of anatomic, clinical, and surgical factors that potentially affect early and long-term results.
Methods: From January 1984 to December 2004, 159 PAAs in 137 patients were operated on at our department. Data
from all the patients were retrospectively collected in a database. PAAs were asymptomatic in 67 cases (42%); 5 (3%) PAAs
were ruptured. In 51 cases (32%), PAA caused intermittent claudication. The remaining 36 limbs (23%) had threatening
ischemia due in 30 cases to acute PAA thrombosis, in 4 cases to chronic PAA thrombosis, and in 2 cases to distal
embolization. In selected patients with acute ischemia, preoperative intra-arterial thrombolysis with urokinase was
performed. Early results in terms of mortality, graft thrombosis, and limb salvage were assessed. Follow-up consisted of
clinical and ultrasonographic examinations at 1, 6, and 12months and yearly thereafter. Long-term survival, patency, and
limb salvage rates were analyzed.
Results: Forty cases were treated with aneurysmectomy and prosthetic graft interposition; in 39 cases, the aneurysm was
opened, and a graft was placed inside the aneurysm. Four patients had aneurysmectomy with end-to-end anastomosis. In
73 cases, ligation of the aneurysm with bypass grafting (39 with a prosthetic graft and 34 with an autologous vein) was
performed. The remaining three patients underwent endovascular exclusion of their PAAs. A medial approach was used
in 97 patients (61%), and a posterior approach was used in 59 patients (37.1%). The outflow vessel was in most cases
(93.7%) the below-knee popliteal artery. Thirty-day amputation and death rates were 4.4% (7/159 limbs) and 2.1%
(3/137 patients), respectively. The amputation rate was significantly higher in symptomatic limbs than in asymptomatic
ones (6.5% and 1.4%, respectively; P .05). Eight limbs (5%) had an early graft thrombosis that required a reintervention.
Follow-up was available in 116 patients (84.7%) and 138 limbs (86%) with a mean follow-up time of 40 months (range,
1-205 months). The cumulative estimated 60-month survival, limb salvage, and primary and secondary patency rates
were 84.2%, 86.7%, 66.3%, and 83.6%, respectively. Asymptomatic limbs had significantly better results than sympto-
matic ones in terms of limb salvage (93.4% and 80.4%, respectively; P  .03; log-rank, 4.2) and primary patency (86.5%
and 51.6%, respectively; P  .001; log-rank, 10.3). Among symptomatic patients, results were better in claudicant limbs
than in acutely ischemic ones in terms of limb salvage (90.5% and 58.7%, respectively; P  .001; log-rank, 17.5).
Univariate analysis showed the absence of symptoms, the presence of two or three tibial vessels, the use of a posterior
approach, the kind of intervention, and the site of distal anastomosis to significantly affect long-term patency. Cox
regression for factors affecting 60-month primary patency showed that clinical presentation, runoff status, and the site of
distal anastomosis significantly influenced long-term results.
Conclusions: Results of surgery on asymptomatic PAAs are good—significantly better than those for symptomatic ones.
Elective surgical intervention should be performed in patients with a low surgical risk and a long life expectancy when the
correct indication exists. In thrombosed aneurysms, intra-arterial thrombolysis may represent an alternative to emergent
surgical management. Our data demonstrated that results are similarly good in claudicants, and this fact confirms that
only acute ischemia due to PAA thrombosis represents a real surgical challenge. In selected patients with focal lesions, a
posterior approach seems to offer better long-term results. The runoff status and the site of distal anastomosis affect
long-term patency as well. ( J Vasc Surg 2006;43:481-7.)Popliteal artery aneurysm (PAA) is uncommon, even
though the popliteal artery is the second most frequent
location of arterial aneurysms.1 PAA is probably a multifac-
torial disease: in elderly patients atherosclerosis seems to be
the main cause,2 whereas in younger patients other causes
have been hypothesized,3 such as popliteal artery entrap-
ment syndrome, cystic adventitial degeneration, osteo-
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doi:10.1016/j.jvs.2005.11.048chondroma, and trauma. The main complications of PAA
include rupture, distal embolization, and thrombosis4;
acute leg ischemia due to thrombosis of the PAA is a
dangerous complication of this pathologic feature and is
often its first clinical manifestation.5 In these circum-
stances, the results of urgent surgical intervention are
poorer than those of elective intervention in asymptomatic
patients and in chronically symptomatic ones.1,6
In recent years, with the introduction and large diffu-
sion of catheter-directed intra-arterial thrombolysis, a com-
bined approach of thrombolysis and surgery has been pro-
posed to optimize the results of surgical intervention.7 The
rationale of thrombolytic treatment is to restore the pa-
tency of the popliteal and tibial vessels, to convert an
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surgical intervention.5,8
Moreover, many perioperative factors may influence
early and late outcomes in terms of survival, limb salvage,
and patency rates.9 In this article, we evaluate the results of
our 20-year experience with surgical management of PAAs,
paying particular attention to different results in different
clinical presentations. We also reviewed the literature in this
field and analyzed any factors potentially affecting early and
long-term results.
MATERIALS AND METHODS
From January 1984 to December 2004, 159 PAAs in
137 patients were operated on at our department. Data
from all the interventions were retrospectively collected in a
dedicated database, which included demographic data, pre-
operative risk factors, clinical and diagnostic assessment,
intraoperative features, and early and long-term outcomes.
Demographic data, clinical status, and diagnostic
assessment. Patients were predominantly male (n  130;
95%; 20 bilateral); 7 patients were female (2 bilateral). The
mean age was 68 years (range, 28-91 years; SD, 10 years).
Considering common risk factors for atherosclerosis, a
history of smoking was present in 70.8% of the patients,
44.5% of the patients had hyperlipemia, diabetes was
present in 6.6% of patients, and arterial hypertension was
present in 54.7%.
Thirty-two patients (23.4%) had coronary artery dis-
ease, and chronic obstructive pulmonary disease was
present in 65 patients (47.4%). Other aneurysm localiza-
tions were present in 47 patients (34%); 42 patients had
aortoiliac aneurysms (previously treated in 30 cases), and 3
had an untreated femoral aneurysm. The remaining two
patients had been treated for a renal artery aneurysm and a
type IV thoracoabdominal aneurysm.
PAAs were asymptomatic in 67 cases (42%). Among
symptomatic PAAs, 51 (32%) caused intermittent claudica-
tion. In five cases (3%) the PAA had ruptured; in all these
cases, the contained rupture was present, with severe pain
and tenderness, subcutaneous ecchymotic lesions, and
painful pulsatility in the popliteal space. The remaining 36
limbs (23%) had threatening ischemia, due in 30 cases to
acute PAA thrombosis, in 4 cases to chronic PAA throm-
bosis, and in 2 cases to distal embolization.
All patients underwent Duplex examination and digital
subtraction angiography before surgery. Our indication for
treating an asymptomatic aneurysm was a diameter greater
than 20 mm. In symptomatic patients, the indication for
surgery was unrelated to the aneurysm’s diameter.
In one third of cases (53 limbs), 3 runoff vessels were
patent; in 56 cases, 2 vessels were patent before surgery.
The remaining limbs had one or no patent distal vessels.
Symptomatic limbs had a significantly lower runoff score
than asymptomatic ones (41 cases [44%] with 2 patent
vessels in symptomatic limbs; 9 cases [13.4%] with 2
patent vessels in asymptomatic ones; P  .001).
Acute ischemia. In selected patients with acutely
thrombosed aneurysms, preoperative catheter-directedthrombolysis with urokinase (Urochinasi Crinos; Crinos
SPA, Milan, Italy) was performed. Thrombolysis was per-
formed in patients with mild to moderate ischemia (grade I
or IIa according to Rutherford’s classification), because
patients with hyperacute ischemia underwent urgent surgi-
cal intervention. Thrombolytic treatment was administered
in a bolus of 100,000 IU, followed by continuous infusion
with a delivery rate of 50,000/70,000 IU/h. In all pa-
tients, 1000 to 1500 IU/h sodium heparin was adminis-
tered via the same catheter to maintain values of activated
partial thromboplastin time two times higher than the
normal value and to prevent pericatheter thrombosis and
complications due to distal embolization.
Angiographic controls were performed daily or more
often, when necessary, and lytic infusion lasted until
patency of popliteal and tibial vessels was achieved or for
a maximum of 3 days when unsuccessful. The levels of
fibrinogen and hemoglobin and the values of interna-
tional normalized ratio and activated partial thrombo-
plastin time were monitored twice a day during throm-
bolytic treatment.
Follow-up. The surveillance program consisted of
clinical and ultrasonographic examinations at 1, 6, and 12
months and yearly thereafter. Until 1990, the follow-up
program consisted of clinical and continuous wave Dopp-
ler examination, with measurement of the ankle-brachial
index; in this period, the graft was considered to be patent
if the ankle-brachial index was unchanged or decreased less
than 0.1 with respect to the values at discharge. Since 1990,
all patients have undergone duplex scanning examination
during follow-up. The patency of the graft and the status of
the anastomoses, inflow and outflow vessels, and contralat-
eral femoropopliteal axis were assessed.
Statistical analysis. Early results in terms of mortality,
graft thrombosis, and amputation rates were analyzed and
compared by 2 text or Fisher exact text. Multivariate
analyses (stepwise logistic regression analysis) for 30-day
mortality, thrombosis, and amputation were performed.
Long-term results (survival, primary and secondary pa-
tency, and limb salvage) were analyzed by Kaplan-Meier
curves, and differences in subgroups were assessed by log-
rank test. For multivariate analysis, the Cox regression test
was used. Statistical analysis was performed with dedicated
software for Windows (SSPS 11; SPSS Inc, Chicago, Ill).
RESULTS
Operative details. Forty cases were treated with aneu-
rysmectomy and prosthetic interposition, whereas in 39
cases the aneurysmwas opened and a graft was placed inside
the aneurysm in a fashion similar to that used to repair
aortic aneurysms. Four patients had aneurysmectomy with
end-to-end anastomosis of the popliteal artery. Aneur-
ysmectomy with graft interposition or end-to-end anasto-
mosis was used in patients with large PAAs limited to the
popliteal space, easily dissectible from surrounding tissues,
or causing compression of veins and nerves or, again, in the
presence of saccular aneurysms. In 73 cases, proximal and
distal ligation of the aneurysm with bypass grafting (39
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performed. The remaining three patients underwent endo-
vascular exclusion of their PAAs.
A medial approach was used in 97 patients (61%), and a
posterior approach was used in 59 patients (37.1%). In
endovascular procedures, a percutaneous contralateral
femoral approach was preferred. Graft materials consisted
of autologous great saphenous vein in 34 cases (21.3%) and
a prosthetic graft in 118 cases (74.2%). As already men-
tioned, four patients had no graft insertion, and three
patients had endoprosthesis placement (Hemobahn; W.L.
Gore&Associates Inc, Flagstaff, Ariz). In 87 interventions,
the inflow vessel was the common or superficial femoral
artery, and in the remaining 72, it was the above-knee
popliteal artery. The outflow vessel was in most cases the
below-knee popliteal artery (93.7%), and in 6.3% of the
cases it was represented by a tibioperoneal trunk or a tibial
vessel. Intraoperative stop-flow thrombolysis10,11 was used
in 11 patients.
Early (<30 days) results. In our series, mortality
was 2.1% (3/137 patients). All the deaths occurred in
patients who had a combined surgical intervention (one
carotid endarterectomy, one open abdominal aortic aneu-
rysm repair, and one contralateral distal bypass). Two pa-
tients were symptomatic (one for rupture and one for
critical leg ischemia).
Amputation occurred in 7 (4.4%) of 159 limbs. Of
these patients, six were symptomatic: five for acute leg
ischemia and one for rupture. The remaining patient was
asymptomatic and died in the early postoperative period as
a result of acute cardiac failure. There was no bilateral
amputation. The amputation rate was significantly higher
in symptomatic limbs than in asymptomatic ones (Table I).
Among symptomatic limbs, results were significantly better
in claudicant patients than in those with acute limb isch-
emia or rupture.
In eight cases (5%), early graft thrombosis occurred and
necessitated a reintervention during the same hospital stay.
All the reinterventions were successful, and neither ampu-
tations nor deaths occurred in these patients. On univariate
analysis, no preoperative risk factor or intraoperative pa-
rameter showed an increased risk for 30-day amputation or
Table I. Thirty-day amputation rates
Variable 30-d amputation rate P value
Asymptomatic 1/67 (1.4%) .05
Symptomatic 6/92 (6.5%)
Claudication 0/51 .001 for acute
ischemia and
rupture vs
claudication
Acute ischemia 5/30 (16.6%)
Rupture 1/5 (20%)
Chronic ischemia 0/6
Total 9/159 (5.6%)death.Preoperative thrombolysis. Seventeen limbs with
mild to moderate acute leg ischemia underwent intra-
arterial preoperative thrombolysis for acutely thrombosed
aneurysms. The median duration of thrombolysis was 13
hours (SD, 34.7 hours); the mean dose of urokinase was
100,000 IU/h per patient (range, 50,000-200,000 IU). In
11 limbs (64.5%), thrombolysis was successful, with com-
plete restoration of patency of the aneurysm and at least of
one tibial vessel. Only one minor hemorrhagic complica-
tion occurred in the femoral puncture site and did not
require a surgical correction.
Long-term results. Follow-up was available in 116 pa-
tients (84.7%) and 138 limbs (86%), with a mean follow-up
time of 40 months (range, 1-205 months). In this period,
13 deaths (none related to previous interventions), 6 am-
putations, and 24 graft thromboses occurred. The cumula-
tive estimated 60-month survival, limb salvage, and primary
and secondary patency were 84.2%, 86.7%, 66.3%, and
83.6%, respectively.
In the group of 24 occluded grafts, 19 patients under-
went treatment for acute limb ischemia; intra-arterial
thrombolysis was performed in 8 cases (followed in 2 cases
by endovascular or surgical associate procedures), whereas
11 patients underwent redo surgical interventions. Five of
the occluded grafts did not require a reintervention because
collateral pathways allowed a sufficient distal perfusion
without the occurrence of critical limb ischemia. In the
entire group, reinterventions were performed in 23 pa-
tients: 19 for graft thrombosis, 3 for anastomotic false
aneurysms, and 1 for graft dilatation.
Analyzing our results on the basis of clinical presenta-
tion, asymptomatic limbs showed significantly better re-
sults in terms of limb salvage and primary patency (Table II;
Figs 1 and 2). Among symptomatic limbs, those with
intermittent claudication had better long-term results in
terms of survival and limb salvage than acutely ischemic
limbs (Table III; Fig 3).
We investigated all possible preoperative and intraop-
erative factors affecting primary patency at 60 months.
Univariate analysis showed the absence of symptoms, the
presence of two or three tibial vessels, the use of a
posterior approach, the kind of intervention, and the site
of distal anastomosis to significantly affect long-term
patency (Table IV). Only clinical presentation, runoff
status, and the site of the distal anastomosis maintained
significance at multivariate analysis (Table V).
DISCUSSION
Several studies have analyzed the natural history of
PAAs. Gifford et al12 reported a complication rate of 76% at
5-year follow-up in 21 patients with untreated asymptom-
atic PAAs. Other studies13,14 demonstrated that 18% to
100% of patients with asymptomatic PAAs developed acute
or chronic limb ischemia; all these patients required a
surgical intervention, with an amputation rate of 13%.
If the PAA remains untreated, the risk of complications
increases over time. Roggo et al15 followed up 45 asympto-
matic patients for 16 years, and all patients developed acute
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within 5 years. Dawson et al1 observed in a follow-up study
on asymptomatic PAAs that 57% of the patients required
surgical intervention (83% within 2 years). Lowell et al14
identified some risk factors for the development of ischemic
complications in patients with an asymptomatic PAA larger
than 20 mm at Duplex scan examination: a poor runoff
status and a large amount of mural thrombus. All these
studies demonstrated that the risk of severe complications,
such as amputation, is high in patients with asymptomatic
aneurysms if they are not promptly treated. As a conse-
quence, considering the good results of reconstructive in-
frainguinal surgery, it is nowadays difficult to justify a
conservative management for this type of disease. Many
authors16,17 recommend elective surgical intervention for
asymptomatic aneurysms larger than 20 mm in patients
months
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Symptomatics (n. at risk) 79 62 39 31 25 16 
Fig 1. Sixty-month estimated limb salvage in symptomatic and
asymptomatic limbs.
Table II. Estimated 60-month results
Variable Symptomatic (%)
Survival 87
Limb salvage 80.4
Primary patency 51.6
Secondary patency 79.6
NS, Not significant.with a low surgical risk. However, several authors6 suggestsurgical reconstruction of any PAA with mural thrombosis,
notwithstanding the diameter of the aneurysm sac.
However, only one third of the patients with PAA are
asymptomatic at diagnosis1; of the remaining two thirds
who have symptoms, nearly 10% have PAA rupture, 5% to
10% have signs and symptoms of nerve or venous compres-
sion, and the remaining patients have limb ischemia.6,8
Also in our series, in most cases (58% of the affected limbs)
signs and symptoms of chronic or acute limb ischemia were
present.
Data from the literature demonstrate that the results of
surgical or endovascular treatment are strongly affected by
the clinical presentation of PAA.18,19,20 The 30-day ampu-
tation rate remains high when the patient is symptomatic.
Reilly et al21 reported an early amputation rate of 35% in 66
patients with acute aneurysmal thrombosis and an amputa-
months
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Fig 2. Sixty-month estimated primary patency in symptomatic
and asymptomatic limbs.
ymptomatic (%) Log-rank P value
81.4 NS
93.4 4.2 .03
86.5 10.3 .001
89.4 NSAstion rate of 15% due to early graft thrombosis. Moreover,
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Other authors22 with large series described amputation
rates ranging from 16% to 43% in patients with acute severe
limb ischemia due to aneurysmal thrombosis. Also, our
results confirm the severity of this clinical situation (16.6%
and 20% of amputations in patients with preoperative acute
limb ischemia and aneurysm rupture, respectively).
The introduction in clinical practice of intra-arterial
thrombolysis has somewhat modified the management of
patients with acute limb ischemia due to a thrombosed PAA.
Many authors23,24 have suggested intra-arterial thrombolysis
as an effective alternative to emergent surgical intervention.
Our previous experience5 demonstrated that preoper-
ative intra-arterial thrombolysis in selected patients with
acute limb ischemia due to aneurysmal thrombosis allowed
months
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58.7%
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Months 0 12 24 36 48 60 
Claudication (n. at risk) 46 37 25 21 16 10 
Acute ischemia (n. at risk) 22 15 10 6 6 4 
Fig 3. Sixty-month estimated limb salvage in symptomatic limbs
(claudication vs acute ischemia).
Table III. Estimated 60-month results in symptomatic pa
Variable
Claudication
(%)
Acute limb
ischemia (%)
Survival 96.6 77.4
Limb salvage 90.5 58.7
Primary patency 50.3 42.1
Secondary patency 83.2 69
NS, Not significant.
*Between claudication and acute limb ischemia.partial or complete recanalization of thrombosed PAAs inapproximately two third of the cases and showed that, when
successful, preoperative thrombolysis provides better re-
sults that urgent surgery alone, without compromising the
s
Chronic limb
ischemia (%)
Rupture
(%) Log-rank P value*
75 66.6 10.7 .03
100 75 17.5 .001
83.3 75 NS
100 75 NS
Table IV. Univariate analysis for primary patency
at 60 months
Variable % Log-rank P value
Clinical presentation
Asymptomatic 86.5
Symptomatic 51.6 10.3 .001
Sex
Male 66.3
Female 75 NS
Smoking
No 64.1
Former 70.5
Yes 59 NS
Hyperlipemia
No 56.5
Yes 72.9 NS
Diabetes
No 65.5
Yes 80 NS
Hypertension
No 64.5
Yes 67.4 NS
Runoff status (vessels)
0 34.4
1 63.3
2 71.9
3 92.8 24.7 .0001
Surgical approach
Medial 55.8
Posterior 82.35 7.1 .007
Intervention
End-to-end anastomosis 100
Aneurysmectomy 71.5
Endoaneurysmectomy 77.6
Ligation and bypass 54.7
Endovascular 100 3.9 .04*
Graft material
Polytetrafluoroethylene 71.5
Vein 79.9 NS
Proximal anastomosis
Common femoral artery 66
Superficial femoral artery 56.1
Popliteal artery 73.2 NS
Distal anastomosis
Popliteal artery 68.6
Tibial vessels 34.6 3.7 .05
NS, Not significant.
*Between endoaneurysmectomy and ligation and bypass.tientresults of surgery if unsuccessful. For this reason, and in the
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patients, we adopted a policy of routine intra-arterial
thrombolysis in patients with mild to moderate acute limb
ischemia due to thrombosis of PAAs.
Good early and late results have been reported with
elective intervention. In a series of 80 asymptomatic and
symptomatic patients who underwent elective surgical in-
tervention, Varga et al6 reported a primary patency of 99%,
with neither deaths nor amputations at the early follow-up.
Similar results were reported in other series,9,13-14 pointing
out the benefits of surgery in asymptomatic patients with
respect to symptomatic ones.
The patency on long-term follow-up seems to be re-
lated to the presence of preoperative symptoms as well. The
primary patency rates at 5 years in asymptomatic patients
ranged from 82% to 97% but decreased to 39% to 70% in
symptomatic ones.25 In our series, only one asymptomatic
patient had an early amputation, and in the asymptomatic
group, the primary patency at 5 years was 86.2%.Moreover,
our data demonstrated that among symptomatic patients,
results are significantly better in the presence of intermit-
tent claudication or chronic ischemia than with acute limb
ischemia or aneurysmal rupture; this result suggests the
need for treating symptomatic patients before major com-
plications occur.
An interesting result is that concerning early mortality: all
deaths occurred in patients who had two combined surgical
procedures. This fact can represent a caveat in choosing to
concomitantly treat patients with multilevel disease.
Other factors described to affect primary patency were
the presence of at least two tibial vessels, the surgical
approach, the graft material, and the site of distal anasto-
mosis. Runoff status significantly influences long-term limb
salvage and primary patency rates.9,26,27,28 In our series,
primary patency at 5 years was 72% in patients with the
presence of at least two tibial vessels, whereas this rate
decreased to 47.4% in patients with a worse runoff status.
Concerning the surgical approach, Mahmood et al29
demonstrated that it was not a predictor of graft failure with
either univariate or multivariate analysis in 52 patients who
underwent operation. Martelli et al30 suggested that the
surgical approach depended on the size and the extent of
the aneurysm; however, they did not find any differences
Table V. Cox regression of factors affecting 60-month
primary patency
Variable
Odds
ratio 95% CI
P
value
Symptomatic 4.9 1.3-17.8 .01
Poor runoff status 10.6 1.9-91.2 .03
Posterior surgical approach 3.8 0.8-18.1 .08
Type of intervention 0.8 0.4-1.8 .7
Graft material 0.6 0.2-2.0 .4
Site of proximal anastomosis 2.2 0.8-5.7 .09
Distal anastomosis on tibial vessels 8.6 1.6-45.1 .01
CI, Confidence interval.between the medial and posterior approach for primarypatency and limb salvage during follow-up. Conversely,
Ouriel31 reported good results with the posterior approach
in occlusive disease that required bypass graft anastomosis
to the proximal third crural vessels. Also in our experience,
at univariate analysis, the posterior approach significantly
improved primary patency at 5 years. This result was not
confirmed at multivariate analysis, thus suggesting that it
can represent a safe and effective approach only in selected
patients with more focal lesions or with good runoff status.
According to many authors, the graft material seems to
influence early and late results.6,25 However, in our expe-
rience, graft material did not influence primary patency at 5
years; for this reason, we use polytetrafluoroethylene as a
safe alternative when autologous vein is not available or
when the revascularization is limited to the popliteal artery.
The site of distal anastomosis seems to affect early and
late outcomes, too. Aulivola et al26 reported the results of
39 patients with 51 PAAs; the outflow vessels were infra-
popliteal vessels in 57% of the cases, and this site of distal
anastomosis played a crucial role in the treatment of PAA,
especially in patients with critical limb ischemia. Indeed, in
our series, the use of an infrapopliteal vessel as the site of
distal anastomosis did affect primary patency at 5 years in
both univariate and multivariate analysis.
CONCLUSIONS
From our study and others, it seems clear that the
results of operation on asymptomatic PAAs are good and
are significantly better than those with operation on symp-
tomatic PAAs. Elective surgical intervention should be
performed in patients with a low surgical risk and with a
long life expectancy in the presence of PAAs with a diame-
ter larger than 2 cm or with a large amount of mural
thrombus found at duplex scan. In thrombosed aneurysms,
intra-arterial thrombolysis may be an alternative to emer-
gent surgical management.
Our data demonstrated that results are similarly good
in claudicants, and this fact confirms that only acute isch-
emia due to PAA thrombosis represents a real surgical
challenge. In our opinion, a policy of elective intervention
in asymptomatic patients with accepted indications for
surgical repair remains the only way to avoid the develop-
ment of acute limb ischemia. In selected patients with focal
lesions, the posterior approach seems to offer better long-
term results. The runoff status and the site of distal anasto-
mosis affect long-term patency as well.
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